Geneia's Fred Rahmanian named one of 10 best CTOs | Geneia

Geneia's Fred Rahmanian named one of 10 best CTOs


February 11, 2020


Geneia's Fred Rahmanian named on of 10 best CTOs

Harrisburg, PAGeneia, a healthcare analytic solutions and services company that is simplifying the transition to value-based care, announced Fred Rahmanian, chief analytics and technology officer, was named to Industry Era’s list of 10 Best CTOs of 2019. Called a “true technological visionary,” Rahmanian earned this distinction for “his decades of experience in software development, data analytics and artificial intelligence” and “his creation and leadership of the Geneia Data Intelligence Lab (GDI Lab).”

“Without a doubt, Fred has earned his spot on the list of 10 Best CTOs,” said Heather Lavoie, president of Geneia. “Under Fred’s leadership, the Geneia Data Intelligence Lab’s use of leading-edge data science to create models that help health plans, hospitals and physician organizations better identify and manage complex and expensive patients is second-to-none.”

At the GDI Lab, Rahmanian leads a team of carefully vetted and trained PhD- and masters-level data scientists, analysts and engineers dedicated to building predictive and increasingly prescriptive models. This rare level of talent and experience means the GDI Lab can develop, interpret and work with unique models and create specific, targeted algorithms related to healthcare cost. Diabetes is a particular focus for Geneia’s clinical team, allowing the lab to leverage their expertise in creating and validating related models.

To read Industry Era’s profile of Rahmanian, click here. To learn more about the GDI Lab, visit: https://content.geneia.com/2019/data-intelligence-lab/index.html.

ABOUT GENEIA

Geneia LLC is a healthcare analytics and services company. We work to improve collaboration between healthcare providers, health plans and employers to better support personalized, patient-centered care. Through advanced technology, education and training, insights and clinical services, we help clients better identify and actively manage high-risk populations, improve quality measurement and outcomes, and strengthen revenue. Rooted in deep clinical experience and leading-edge data science, our client-centric, phased approach to population health simplifies the transition to risk and value-based care. Our offices are located in Harrisburg, PA and Manchester, NH. To learn more, visit Geneia.com (https://www.geneia.com) or connect with us on Facebook, Twitter and LinkedIn.